Retrospective analysis of prenatal screening on 9338 cases in the city of Quanzhou
FU Qing-li
Abstract
FU Qing-li
Abstract
Objective: To evaluate the clinic value of the double marker prenatal screening system for Down′s syndrome(DS),trisomy 18 and neural tube defects(NTD).Methods: Double label time-resolved fluorescence method was used to test the concentrations of AFP and Free-β-hCG in the serum of 9338 middle period pregnant women who were pregnant for 15-20+6 weeks.combined with gestational age,weight,age and other factors,we evaluated the risk assessment with assessment software.Results: In 9338 cases,the positive rate 4.7%(437/9338),with 2.8%(262 cases)of Downs syndrome and 1.3%(119 cases) of NTD and 0.6%(56 cases) of 18-trisome syndrome.Conclusion: The combination of the serum biochemistry results of AFP and Free-β-hCG can effectively reduce congenital fetal malformtion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the clinic value of the double marker prenatal screening system for Down′s syndrome(DS),trisomy 18 and neural tube defects(NTD).Methods: Double label time-resolved fluorescence method was used to test the concentrations of AFP and Free-β-hCG in the serum of 9338 middle period pregnant women who were pregnant for 15-20+6 weeks.combined with gestational age,weight,age and other factors,we evaluated the risk assessment with assessment software.Results: In 9338 cases,the positive rate 4.7%(437/9338),with 2.8%(262 cases)of Downs syndrome and 1.3%(119 cases) of NTD and 0.6%(56 cases) of 18-trisome syndrome.Conclusion: The combination of the serum biochemistry results of AFP and Free-β-hCG can effectively reduce congenital fetal malformtion.
Key concepts: Prenatal screening, Trisomy, Medicine, Down syndrome, Fetus, Prenatal diagnosis, Obstetrics, Gestational age